These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability. Liao F; Doody JF; Overholser J; Finnerty B; Bassi R; Wu Y; Dejana E; Kussie P; Bohlen P; Hicklin DJ Cancer Res; 2002 May; 62(9):2567-75. PubMed ID: 11980651 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherin. Lamszus K; Brockmann MA; Eckerich C; Bohlen P; May C; Mangold U; Fillbrandt R; Westphal M Clin Cancer Res; 2005 Jul; 11(13):4934-40. PubMed ID: 16000592 [TBL] [Abstract][Full Text] [Related]
6. Green tea catechins inhibit VEGF-induced angiogenesis in vitro through suppression of VE-cadherin phosphorylation and inactivation of Akt molecule. Tang FY; Nguyen N; Meydani M Int J Cancer; 2003 Oct; 106(6):871-8. PubMed ID: 12918064 [TBL] [Abstract][Full Text] [Related]
7. The vascular endothelial growth factor/fms-like tyrosine kinase system in human ovary during the menstrual cycle and early pregnancy. Otani N; Minami S; Yamoto M; Shikone T; Otani H; Nishiyama R; Otani T; Nakano R J Clin Endocrinol Metab; 1999 Oct; 84(10):3845-51. PubMed ID: 10523040 [TBL] [Abstract][Full Text] [Related]
8. Administration of a gonadotropin-releasing hormone agonist affects corpus luteum vascular stability and development and induces luteal apoptosis in a rat model of ovarian hyperstimulation syndrome. Scotti L; Irusta G; Abramovich D; Tesone M; Parborell F Mol Cell Endocrinol; 2011 Mar; 335(2):116-25. PubMed ID: 21238536 [TBL] [Abstract][Full Text] [Related]
9. The role of differential VE-cadherin dynamics in cell rearrangement during angiogenesis. Bentley K; Franco CA; Philippides A; Blanco R; Dierkes M; Gebala V; Stanchi F; Jones M; Aspalter IM; Cagna G; Weström S; Claesson-Welsh L; Vestweber D; Gerhardt H Nat Cell Biol; 2014 Apr; 16(4):309-21. PubMed ID: 24658686 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of vascular endothelial growth factor in the primate ovary up-regulates hypoxia-inducible factor-1alpha in the follicle and corpus luteum. Duncan WC; van den Driesche S; Fraser HM Endocrinology; 2008 Jul; 149(7):3313-20. PubMed ID: 18388198 [TBL] [Abstract][Full Text] [Related]
11. Role of vascular endothelial growth factor in ovarian physiology - an overview. Kaczmarek MM; Schams D; Ziecik AJ Reprod Biol; 2005 Jul; 5(2):111-36. PubMed ID: 16100562 [TBL] [Abstract][Full Text] [Related]
12. Identification of a transiently exposed VE-cadherin epitope that allows for specific targeting of an antibody to the tumor neovasculature. May C; Doody JF; Abdullah R; Balderes P; Xu X; Chen CP; Zhu Z; Shapiro L; Kussie P; Hicklin DJ; Liao F; Bohlen P Blood; 2005 Jun; 105(11):4337-44. PubMed ID: 15701713 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of vascular endothelial growth factor-induced angiogenesis by resveratrol through interruption of Src-dependent vascular endothelial cadherin tyrosine phosphorylation. Lin MT; Yen ML; Lin CY; Kuo ML Mol Pharmacol; 2003 Nov; 64(5):1029-36. PubMed ID: 14573751 [TBL] [Abstract][Full Text] [Related]
14. Messenger ribonucleic acids for MAC25 and connective tissue growth factor (CTGF) are inversely regulated during folliculogenesis and early luteogenesis. Wandji SA; Gadsby JE; Barber JA; Hammond JM Endocrinology; 2000 Jul; 141(7):2648-57. PubMed ID: 10875270 [TBL] [Abstract][Full Text] [Related]
15. Human chorionic gonadotropin controls luteal vascular permeability via vascular endothelial growth factor by down-regulation of a cascade of adhesion proteins. Herr D; Fraser HM; Konrad R; Holzheu I; Kreienberg R; Wulff C Fertil Steril; 2013 May; 99(6):1749-58. PubMed ID: 23465821 [TBL] [Abstract][Full Text] [Related]
16. Low-dose dopamine agonist administration blocks vascular endothelial growth factor (VEGF)-mediated vascular hyperpermeability without altering VEGF receptor 2-dependent luteal angiogenesis in a rat ovarian hyperstimulation model. Gomez R; Gonzalez-Izquierdo M; Zimmermann RC; Novella-Maestre E; Alonso-Muriel I; Sanchez-Criado J; Remohi J; Simon C; Pellicer A Endocrinology; 2006 Nov; 147(11):5400-11. PubMed ID: 16901966 [TBL] [Abstract][Full Text] [Related]